UNSPSC 51401601: Bentazepam

This classification denotes a sedative, hypnotic, and anxiolytic with the molecular formula C17H16N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 66JKK43S1Z, chemically known as 1,3,6,7,8,9-hexahydro-5-phenyl-2h-(1)benzothieno(2,3-e)-1,4-diazepin-2-one but generally known as bentazepam, which bears US NIH Compound Identifier 34592. European Medicines Agency schedules Bentazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05733MIG.

UNSPSC 51401601 Bentazepam is a Commodity code that state and local governments use to tag pharmaceutical and medical supply procurements, though the recent activity under this code shows a mismatch between its nominal scope and what is actually being solicited. Seminole County, Florida issued an IFB (Solicitation Number IFB60459723LAS, posted June 30, 2026, due July 26, 2023) seeking to procure naloxone and safe drug deactivation systems annually — opioid-reversal medication and harm-reduction equipment tied to community health initiatives, not bentazepam. The work involves quarterly deliveries to a county health facility, with vendors responsible for shipping and delivery costs, electronic bid submission, drug-free workplace certification, E-Verify compliance, workers' compensation and liability insurance, and a three-month probationary termination right for the county. The contract structure includes a two-year initial term with a one-year renewal option and fixed-fee pricing, with potential FEMA funding and federal environmental compliance requirements (Clean Air Act, Federal Water Pollution Control Act). No explicit set-aside designations appear in the solicitation.

The recent opportunity activity under this code is limited to the single Seminole County procurement, which appears to be tagged under Bentazepam despite procuring naloxone and deactivation systems instead. No additional representative solicitations from other state or local issuing bodies are evident in the source material. Geographic activity is concentrated in Florida based on this single posting. The code shows little relevant recent activity aligned with its nominal pharmaceutical scope, and the one indexed opportunity involves harm-reduction and community health equipment rather than bentazepam itself.